P. Reaves

发表

Decrease in Hypothalamic Gamma Adducin in Rat Models of Hypertension

Hong Yang, M. Raizada, M. Katovich, 2004, Hypertension.

Reversal of hypertension by angiotensin II type 1 receptor antisense gene therapy in the adult SHR.

M. Raizada, M. Katovich, H. Wang, 1999, The American journal of physiology.

Angiotensin I-converting enzyme antisense gene therapy causes permanent antihypertensive effects in the SHR.

M. Raizada, M. Katovich, H. Wang, 2000, Hypertension.

Targeting of the renin‐angiotensin system by antisense gene therapy: a possible strategy for the long‐term control of hypertension

M. Raizada, M. Katovich, Hongwei Wang, 2000, Journal of hypertension.

Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension

M. Raizada, M. Katovich, Hong-wei Wang, 2001, Journal of hypertension.

Structural Remodeling of Cardiac Myocytes in Patients With Ischemic Cardiomyopathy

K E Muffly, A. Gerdes, D. Schocken, 1992, Circulation.

Left Ventricular Hypertrophy, Cardiac Myocyte Adaptation, and Collagen/Parenchymal Distribution in Response to Subpressor and Pressor Doses of Angiotensin II in Sprague-Dawley Rats

M. S. Holder, O. Kirksey, P. Reaves, 2008 .

Effects of early perturbation of the renin-angiotensin system on cardiovascular remodeling in spontaneously hypertensive rats.

M. Raizada, K. Berecek, P. Reaves, 2005, Vascular pharmacology.

Angiotensin II type 1 receptor antisense gene therapy prevents altered renal vascular calcium homeostasis in hypertension.

M. Raizada, M. Katovich, H. Wang, 1999, Hypertension.

Angiotensin I-converting enzyme antisense prevents altered renal vascular reactivity, but not high blood pressure, in spontaneously hypertensive rats.

M. Raizada, M. Katovich, H. Wang, 2000, Hypertension.

Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy.

J. Martens, D. Lu, M. Raizada, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Attenuation of hypertension by systemic delivery of retroviral vector containing type I angiotensin II receptor antisense cDNA.

M. Raizada, M. Katovich, H. Wang, 2000, Methods.

Structural Remodeling ofCardiac Myocytes in Patients WithIschemic Cardiomyopathy

A. Gerdes, D. Schocken, P. Mckeown, 2011 .

Losartan versus gene therapy: chronic control of high blood pressure in spontaneously hypertensive rats.

D. Lu, M. Raizada, M. Katovich, 1997, Hypertension.

Large-scale production of retroviral vectors for systemic gene delivery.

M. Huentelman, M. Raizada, M. Katovich, 2002, Methods in enzymology.

Sustained inhibition of angiotensin I-converting enzyme (ACE) expression and long-term antihypertensive action by virally mediated delivery of ACE antisense cDNA.

M. Raizada, M. Katovich, M. Phillips, 1999, Circulation research.

Endothelial‐Independent Prevention of High Blood Pressure in L‐Name‐Treated Rats by Angiotensin II type I Receptor Antisense Gene Therapy

M. Raizada, M. Katovich, Hongwei Wang, 2003, Experimental physiology.

Permanent cardiovascular protection from hypertension by the AT(1) receptor antisense gene therapy in hypertensive rat offspring.

D. Lu, M. Raizada, K. Berecek, 1999, Circulation research.

Culturally-Sensitive Wellness Challenge Interventions in Predominantly African American Adults in the Southern Region of Florida: An Observational Study

R. Williams, M. S. Holder, O. Kirksey, 2008 .

Climate Change Impacts on Human Health

Kristina W. Kintziger, S. Ryan, P. Reaves, 2017 .